Reversal of hyperlipidemia and lipodystrophy in patients switching therapy to nelfinavir.
Explore the source record for details and available documents.
Anti-HIV Agents↗
SEARCH · Search PubMed
Results for “Nelfinavir”
Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Performance of a quadruple combination including nelfinavir plus efavirenz in naive subjects with high baseline viral load and in patients failing protease inhibitor-containing regimens.
Explore the source record for details and available documents.
Alkynes↗
Lack of association between pregnancy and selected gastrointestinal adverse events among women prescribed nelfinavir.
Explore the source record for details and available documents.
Adolescent↗
Lopinavir/r versus nelfinavir as salvage therapy.
Explore the source record for details and available documents.
Child↗
The effect of the CYP2C19*2 heterozygote genotype on the pharmacokinetics of nelfinavir.
Explore the source record for details and available documents.
Aryl Hydrocarbon Hydroxylases↗
Virologic response of nine therapy-experienced children receiving 64 weeks of nelfinavir salvage therapy.
Explore the source record for details and available documents.
Anti-HIV Agents↗
Decrease in methodone levels with nelfinavir mesylate.
Explore the source record for details and available documents.
Adult↗
Four-drug salvage antiretroviral treatment including nelfinavir and efavirenz in highly treated children with congenital HIV disease.
Explore the source record for details and available documents.
Alkynes↗
Exacerbated hyperglycemia associated with nelfinavir.
Explore the source record for details and available documents.
Diabetes Complications↗
[The role of nelfinavir in the triple-therapy of HIV infection].
Explore the source record for details and available documents.
Anti-HIV Agents↗
Two possible pathways for acquisition of mutations related to nelfinavir resistance.
Explore the source record for details and available documents.
Drug Resistance, Microbial↗
Ongoing open-label trials of triple therapy with stavudine and lamivudine or stavudine and didanosine plus nelfinavir.
The VZN and ZEN studies are non-comparative trials assessing triple combination therapy comprising thymidine and non-thymidine analogue nucleoside reverse transcriptase inhibitors plus a protease inhibitor. Preliminary data are available for the VZN study and recruitment for the ZEN study is underway.
Adult↗
Pancrelipase for treatment-refractory diarrhea associated with nelfinavir.
Explore the source record for details and available documents.
Adult↗
Long-term stability of nelfinavir mesylate in human plasma.
Explore the source record for details and available documents.
Anticoagulants↗
ICAAC: nelfinavir interacts with statins and an antiseizure drug.
Explore the source record for details and available documents.
Anticholesteremic Agents↗
Nelfinavir study recruiting in eight cities.
Explore the source record for details and available documents.
Acquired Immunodeficiency Syndrome↗
Anti-HIV effects of nelfinavir reported after ten months of combination therapy.
Explore the source record for details and available documents.
Anti-HIV Agents↗
Nelfinavir produces durable anti-HIV effects for two years.
Explore the source record for details and available documents.
Acquired Immunodeficiency Syndrome↗